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Fabrication and evaluation of poly(lactic acid), chitosan, and tricalcium
phosphate biocomposites for guided bone regeneration
Abstract
This study presents and evaluates an approach for fabricating poly(lactic acid) (PLA)/chitosan
(CS)/tricalcium phosphate (TCP) electrospun scaffolds for guided bone regeneration, a dental procedure
that uses membranes to direct and delineate regions of osteogenesis. Biomaterials were pre‐processed using
cryomilling, a solid‐state grinding technique that facilitates the generation of powdered biocomposites
conducive to electrospinning. X‐ray diffraction (XRD) confirmed the generation of cryomilled blends
consisting of PLA, CS, and TCP. Results from the differential scanning calorimetry showed an upward shift in
glass transition temperature and an increase in crystallinity with the inclusion of TCP reinforcing the
observations from XRD. Murine macrophages were used to confirm the biocompatibility of the cryomilled
powders and was evaluated using CellTiter‐Blue (CTB) cell viability assay and brightfield microscopy.
Scanning electron microscopy was used to examine the morphology of the fibers produced via
electrospinning, while Raman spectroscopy confirmed material homogeneity. In vitro studies with MG‐63
cells validated the capacity of composite scaffolds to encourage proliferation, while Coherent anti‐Stokes
Raman scattering and fluorescence microscopies provided visual evidence of cell proliferation. CTB assay
revealed that cells maintain viability and metabolic activity at 3 and 7 days after seeding, demonstrating the
potential of the biocomposite membranes.
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ABSTRACT: This study presents and evaluates an approach for fabricating poly(lactic acid) (PLA)/chitosan (CS)/tricalcium phosphate (TCP)
electrospun scaffolds for guided bone regeneration, a dental procedure that uses membranes to direct and delineate regions of osteogenesis.
Biomaterials were pre-processed using cryomilling, a solid-state grinding technique that facilitates the generation of powdered biocomposites
conducive to electrospinning. X-ray diffraction (XRD) conﬁrmed the generation of cryomilled blends consisting of PLA, CS, and TCP.
Results from the differential scanning calorimetry showed an upward shift in glass transition temperature and an increase in crystallinity
with the inclusion of TCP reinforcing the observations from XRD. Murine macrophages were used to conﬁrm the biocompatibility of the
cryomilled powders and was evaluated using CellTiter-Blue (CTB) cell viability assay and brightﬁeld microscopy. Scanning electron micros-
copy was used to examine the morphology of the ﬁbers produced via electrospinning, while Raman spectroscopy conﬁrmed material homo-
geneity. In vitro studies with MG-63 cells validated the capacity of composite scaffolds to encourage proliferation, while Coherent anti-
Stokes Raman scattering and ﬂuorescence microscopies provided visual evidence of cell proliferation. CTB assay revealed that cells maintain
viability and metabolic activity at 3 and 7 days after seeding, demonstrating the potential of the biocomposite membranes. © 2018 The Authors.
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INTRODUCTION
In the recent years, increasing interest in developing dental proce-
dures for bone regeneration has been driven by the growing number
of patients requiring such interventions. Data from National Health
and Nutrition Examination Survey (NHANES) suggests that 64.7
million adults in the USA suffer from periodontitis, a dental disease
characterized by the destruction of the connective tissue and dental
bone.1 Guided bone regeneration (GBR), when applied, has been able
to treat bone defects caused by periodontitis.2 In principle, GBR uses
barrier membranes to prevent the entry and proliferation of non-
osteogenic cells in defect sites by selectively promoting the growth of
osteogenic cells.3 Therefore, the procedure’s success, among other
factors, is also largely dependent on the design and performance of
the barrier membrane. A suitable barrier membrane is expected to
possess biocompatibility, mechanical strength, and pliability at the
time of implantation.4 Expanded polytetraﬂuoroethylene (e-PTFE)
has dominated as the material for the fabrication of non-resorbable
membranes which needs to be surgically removal.5 However, resorb-
able membranes offer an interesting alternative making the process
more patient-friendly.6 Polymers such as chitosan (CS), collagen,
poly(lactic acid) (PLA), poly(ϵ-caprolactone) (PCL), and
poly(lactic-co-glycolic acid) (PLGA) have been used individually,
or in blends, for the fabrication for such membranes.7
In recent years, there has been an increased focus in the develop-
ment and investigation of new polymeric blends that can possess
superior mechanical and biological properties in comparison to
commercially available single biopolymers. For example, Guo et al.8
reported the potential of PLGA/PLLA/PDLA blend ﬁbers loaded
with naringin for GBR. In another study, a mixture of chitosan, colla-
gen, and poly(ethylene oxide) was used to make up a nanoﬁber
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chitosan-collagen membrane to be used in GBR.9 Currently, the
enhancement of polyester-based membranes by the addition of inor-
ganic and organic materials is also being investigated widely.10–12 In
that regard, this study explores and evaluates the preparation
approach and performance of novel biocomposite membranes con-
sisting of PLA, CS, and tricalcium phosphate (TCP).
CS, a natural occurring biodegradable polymer, has antimicrobial
properties that are desirable in resorbable membranes but inferior
mechanical properties and unsuitable degradation rate have limited
its exclusive use.13,14 On the other hand, PLA, a synthetic polymer
known for its suitable mechanical strength and biocompatibility has
been used in the fabrication of commercially available membranes
for two decades now.15 Despite these favorable properties, the release
of oligomers and acid byproducts during degradation has necessi-
tated the need to tune its properties with ceramic ﬁllers such as
TCP.16 Apart from being used to enhance the material strength, TCP
also ensures the presence of an ideal ionic environment for bone
regeneration. Composite materials thus facilitate the fabrication of
tailor-made membranes that can exhibit positive synergistic effects.
However, the challenges of attaining uniform dispersions and the
possible denaturing of biomolecules remain a hurdle to the success
of traditional compatibilization strategies.17
To overcome the above-mentioned challenges associated with mix-
ing strategies, cryomilling, a solid-state, low temperature grinding
process was employed in this study to generate blends of PLA, CS,
and TCP. Electrospinning was then utilized to fabricate ﬁbrous
membranes due to its previous success in bone tissue engineering.18
Material properties of cryomilled biocomposites and electrospun
ﬁbers were analyzed using X-ray diffraction (XRD), differential
scanning calorimetry (DSC), scanning electron microscopy (SEM),
and Raman spectroscopy. Murine macrophages (RAW 264.7) were
used to investigate the cytocompatibility of the biocomposite pow-
ders via CellTiter-Blue (CTB) cell viability assay. The electrospun
membranes were also evaluated for their capacity to support the
growth of model osteoblasts (MG-6f3 osteosarcoma cells) using
CTB cell viability assay as seen elsewhere.19–21 A second viability
assay employing ﬂuorescence and coherent anti-Stokes Raman scat-
tering (CARS) microscopies allowed simultaneous imaging of the
ﬁbers and cells.
In this manner, this research validates an effective approach for the
fabrication of novel poly(lactide)-based biocomposites membranes
through morphological, thermal, and structural characterization. In
addition, this work also serves as a preliminary study for using novel
PLA/CS/TCP blends for GBR applications by studying the attach-
ment of MG-63 cells on the generated biocomposites scaffolds.
EXPERIMENTAL
Fabrication of Powder Biocomposite
PLA (Purasorb PL 10; Purac, The Netherlands), CS (448877-50G,
Medium Mw; Sigma-Aldrich, Irvine, UK), and TCP
(C5267-100G, 34.0–40.0% Ca basis; Sigma-Aldrich) were cryo-
milled to generate powdered composites. Compositions of the
blends prepared in this study is as follows: A0: 100% PLA; A1:
70% PLA, 30% CS; A2: 68% PLA, 30% CS, 2% TCP; A3: 66%
PLA, 30% CS, 4% TCP. The sample-containing vials were loaded
into the freezer mill (6870; SPEX, Metuchen, NJ) which was
maintained at −196 C. The samples were cryomilled for 20 min
(4 milling cycles).22 A cooling time of 1 min was allowed between
successive cycles and a precool time of 15 min was utilized to
ensure homogeneity in temperature at the time of milling.23 The
samples were stored in a silica-ﬁlled desiccator for at least 48 h at
room temperature before further processing or analysis.
Characterization of Powder Biocomposite
Conﬁrmation for the production of a composite blend was
achieved using the Rigaku Miniﬂex 600 XRD analysis unit (Tokyo,
Japan) equipped with a Cu-Kα radiation source (λ = 0.154 nm).
The voltage and current applied were 30 kV and 15 mA, respec-
tively. The scan ranged from 3 to 80 with steps of 0.02.
Thermal characterization of the powders produced was performed
using a differential scanning calorimeter (DSC) (Phoenix, NETZSCH
Instruments, Burlington, MA). To avoid the degradation of CS, the
method of Sakurai et al.24 was used with modiﬁcations. Suyatma
et al.25 reported the success of the modiﬁed method in characterizing
PLA/CS biodegradable ﬁlms. 8 mg of the sample were quenched at
10 C min−1 to −30 C before being heated to 190 C at the same
rate. The samples were held at 190 C for 1 min before being cooled
down to −30 C. The samples were then held at −30 C for 3 min
before the second heating cycle in which the samples were heated to
250 C. The second heating scan was used to identify the glass transi-
tion and melting temperatures along with percent crystallinity. Pro-
teus Thermal Analysis version 6.1.0 was used for the analysis.
Cytotoxicity Study for Biocomposite Powder
Powders A0, A1, A2, and A3 were weighed and suspended in a
standard DMEM medium (Sigma-Aldrich) at a concentration of
0.84% w/v, creating four different stock media. Each stock
medium was then autoclaved at 121 C for 15 min, cooled to
room temperature, and diluted using the standard medium to
give particle dose concentrations of 0.3 × 106, 1 × 106, 3 × 106,
and 5 × 106 particles mL−1. The dosing calculations were carried
out assuming a modal particle diameter of 5 μm and a density of
1.2 g cm−3 for the composite material. The new solutions were
named CompA0, CompA1, CompA2, and CompA3 medium.
The RAW264.7 murine macrophage cell line was used to test the
cytocompatibility of CompA0-A3 medium. The cells, at passage
12, were cultivated in DMEM medium (Sigma-Aldrich) supple-
mented with 10% fetal bovine serum (FBS) and 1% penicillin/
streptomycin (Invitrogen, Paisley, UK). When conﬂuent, cells
were trypsinized, and subsequently seeded into a 96-well plate at
the concentration of 3 × 104 cells/well in a volume of 100 μL of
DMEM. Cells were then incubated for 24 h at 37 C, 5% CO2,
and subsequently exposed to CompA0-A3 media in 100 μL of
medium/well. This yielded an approximate load of 10, 30,
100, and 200 particles per cell. Cells were incubated for a further
24 h and imaged using bright-ﬁeld microscopy at 200× magniﬁ-
cation (Leica Microsystem, Milton Keynes, UK). Next,
CompA0-A3 media was replaced with fresh DMEM and cells
were incubated for further 24 and 48 h, before proceeding with
the CTB cell viability assay (Promega, Southampton, UK). Brieﬂy,
20 μL/well of the reagent were added to cells grown in a 96-well
plate which were subsequently incubated at 37 C, 5% CO2 for
3 h. At the end of incubation, the supernatant of each well was
transferred to a fresh 96-well plate and ﬂuorescence was measured
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with a microplate reader at 560/690 nm (Modulus II Microplate
Multimode Reader, Turner Biosystems, Sunnyvale, CA). Cells
grown in DMEM were used as negative controls and all experi-
ments were conducted in triplicate. Data are expressed as mean ±
standard deviation (SD).
Fabrication of Resorbable Membranes
Electrospinning was employed to generate ﬁbrous membranes
using the cryomilled biocomposites. Triﬂuoroacetic acid (TFA)
(O4902-100; Fisher Scientiﬁc) was used as the solvent. In a typi-
cal process, 18 w/v % of the cryomilled powder was added to
5 mL of TFA, and stirred using a magnetic stirrer at 25 C for at
least 24 h. A stationary copper plate covered with aluminum foil
was used as the collector. The needle tip to collector distance was
set to 13 cm, and the potential difference was adjusted between
15 and 17.5 kV as needed, with a ﬂow rate of 0.05 mL min−1.
Characterization of Resorbable Membranes
SEM (JCM-6000Plus NeoScope JEOL, Peabody, MA) was used to
conﬁrm the successful production of electrospun ﬁbrous mem-
branes. Fiber diameter was measured using JCM-6000 software
version 1.1. The mean diameters of the membranes were calcu-
lated using 30 measurements from three independent samples.
All diameters are represented as mean ± SD.
Further quality assurance for ﬁber production was conducted
with NIR Raman spectroscopy. Electrospun membranes of A0,
A1, A2, and A3 were cut into four different pieces and sterilized
by UV irradiation for 15 min. Raman spectra were recorded at
20 different locations across each sample (4 × 5 grid with
200 μm spacing) using a Renishaw InVia microscope (785 nm
excitation, 65 mW at the sample, ×40 objective giving a 10 μm
focal spot diameter). Spectra were dispersed by a 600 lines/mm
grating onto a thermoelectrically cooled CCD, yielding a spectral
resolution of 7 cm−1 across a sampling range 400–3200 cm−1
wavenumbers of Stokes shift.
Performance Assessment of Resorbable Membranes
MG-63 human osteosarcoma cell line was cultivated in DMEM
medium (Sigma-Aldrich) supplemented with 10% FBS and 1%
penicillin/streptomycin (Invitrogen). When conﬂuent, cells were
trypsinized, and suspended into 30 μL of medium and subse-
quently seeded onto the scaffolds (7.5 × 104 cells/scaffold). Before
cell seeding, scaffolds were placed one per well in a sterile 48-well
plate, UV irradiated for 15 min and pre-soaked into DMEM for
10 min. Cell attachment was encouraged by incubating scaffolds
at 37 C, 5% CO2 for 15 min and then 500 μL of DMEM were
added to each scaffold. The media was changed every 3 days,
with cell viability being investigated after 3 and 7 days using the
CTB assay. At the end of the incubation period, 100 μL of CTB
solution were added to scaffolds, which were incubated at 37 C,
5% CO2 for 3 h. Then, the supernatant from each well, together
with the scaffolds, were transferred into a fresh microvial which
was centrifuged at 1000 rpm for a minute. The supernatants were
put into a fresh microvial and vortexed. 100 μL of the superna-
tants were transferred into a glass bottom microplate, and ﬂuo-
rescence was measured at 560/690 nm. Samples were investigated
in triplicate. All data are expressed as mean ± SD.
Imaging was also used to assess cell viability using LIVE/DEAD
staining (Invitrogen). The cell-laden scaffolds were incubated with
Calcein acetoxymethyl (Calcein-AM) 2 μM plus ethidium
homodimer-1(EthD-1) 4 μM for 15 min at 37 C, 5% CO2, in the
dark. Scaffolds were gently washed with 1 mL of PBS post-
incubation. Fluorescent dyes were excited and imaged using two-
photon emission ﬂuorescence (TPEF), while ﬁbrous scaffolds were
resolved using CARS. TPEF was read using two bandpass ﬁlters;
for green ﬂuorescence, a 515/42 nm combined with a 535/40 nm
and for red ﬂuorescent marker, the 609/54 and 640/14 nm (all
Semrock). For CARS, a 1064 nm (Stokes beam) and 810.3 nm
(pump beam) were used to excite the 2940 cm−1 CH stretch
vibration, signal was selected using a 660/13 nm bandpass ﬁlter.
Statistical Analysis
Results of the CTB cell viability assays were analyzed using
PRISM version 7.0 (GraphPad Software, San Diego, CA) with
95% conﬁdence intervals (CI) of the difference. Two-way
ANOVA was performed to evaluate statistical signiﬁcance with a
designated Type I error rate of 0.05%.
RESULTS AND DISCUSSION
Morphology of Cryomilled Composite Powders
SEM was utilized to evaluate the morphology of the cryomilled
biocomposite particles in comparison to as-received, non-
cryomilled PLA. The composite powders were composed of
sharp-edged particles ranging in size (across all the composite
blends) from 15 to 20 μm, signiﬁcantly smaller than the particle
size of the materials before cryomilling [Figure 1(a,b)]. Addition-
ally, dry agglomeration of particles was also observed.
Figure 1. Representative SEM images of (a) as-received non-cryomilled PLA and (b) cryomilled PLA/CS/TCP (A3).
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The primary step in the membrane fabrication process was to uti-
lize cryomilling to generate a ﬁne powder blend of PLA, CS, and
TCP. Cryomilling, being a mechanical attrition process, subjects
the materials to repeated fracturing and welding by means of col-
lisions with a high-energy impactor bar. Other than being a sol-
ventless process, the use of cryomilling provided two beneﬁts
(a) it reduced the size disparity between the as-received PLA, CS,
and TCP particles thus avoiding granular convective effects,26
and (b) it generated a ﬁne powder blend of dissimilar materials
making it easier for dispersion in solvents. It was possible to
attain a considerable reduction in particle size in short period of
processing because the polymers were milled below their glass
transition temperature which facilitated the occurrence of brittle
fractures.27,28 The cryomilled powders showed signs of dry
agglomeration due to electrostatic and van der Waals forces
between the particles.29–31
X-Ray Diffraction Analysis
XRD was utilized to conﬁrm the successful production of powder
blends consisting of PLA, CS, and TCP. Figure 2 shows the XRD
proﬁles for as-received PLA, CS, and TCP along with the proﬁles
for the composite blends prepared by cryomilling. The
as-received PLA exhibited a very strong crystalline peak centered
at 2θ= 16.38 and a relatively weak peak at 2θ = 18.72. For the
CS, a sharp diffraction peak was observed at 2θ = 19.44 and a
weak peak centered around 2θ = 9.34. The as-received TCP
showed a lot of distinct peaks with high intensity peaks at
2θ = 25.66, 2θ = 31.58, and 2θ = 32.68. All of the results for
composite blends A1, A2, and A3 showed similar PLA diffraction
peaks at 2θ = 16.38 and 19.44. However, the diffractograms of
all the CS-containing blends showed an increase in intensity at
2θ ≈ 20 when compared to the proﬁle of pure PLA. For blends
A2 and A3, an additional peak was observed at 2θ = 32 which
appeared to grow with increasing TCP content in the polymer
matrix.
PLA showed the typical proﬁle of a semi-crystalline polymer consist-
ing of both crystalline and amorphous regions. The positions of the
peaks aligned with results reported previously.32 The strong crystal-
line peak of PLA corresponded to the (110) and/or (200) plane of a
typical orthorhombic crystal.33 The two peaks shown by CS were
indicative of the hydrated crystalline nature of the material.34 The CS
peaks at angles 2θ = 9.34 and 19.44 corresponded to d-spacing
values of 0.95 and 0.45 nm which matched previous ﬁndings.35 Also,
TCP peaks at 2θ= 25.66, 2θ = 31.58, 2θ = 32.68, 2θ = 33.86,
2θ = 39.60, and 46.54 conﬁrmed the presence of TCP.36 For all
three composite blends, the increase in intensity around 2θ ≈ 20
was indicative of the presence of CS and the growing intensity of the
peak around 2θ ≈ 32 with increasing TCP content reﬂected a suc-
cessful inclusion of the ceramic component in the polymer matrix.37
The proﬁles of the composite blends were observed to be inﬂuenced
by those of the individual materials indicating that the materials
blended only on a physical-level. On the whole, the XRD data sub-
stantiated the ability of cryomilling to generate a blend of dissimilar
materials.
Figure 2. XRD proﬁles of composite blends along with their individual components.
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Differential Scanning Calorimetry Analysis
DSC was used to quantify the glass transition and melting tem-
peratures as well as crystallinity of PLA and the composite pow-
der blends. The thermograms from the second heating scan are
shown in Figure 3 while associated thermal parameters are
reported in Table I. DSC curve of pure PLA revealed an average
glass transition temperature of 57.6 C followed by an endother-
mic melting peak at 177.5 C with an enthalpy of fusion of 14.5 J
g−1. It was observed that the introduction of CS into the PLA
matrix produced an increase in the glass transition temperature
while decreasing crystallinity. The percent crystallinity was
enhanced by the inclusion of the bioceramic, increasing to 23.9%
and 27.8% with the addition of 2 and 4 wt % TCP, respectively, in
comparison to the 15.2% computed for pure PLA.
The second heating scan was used to conduct the analysis as it
allowed for the direct comparison of materials. The glass transition
temperature of PLA obtained in this study was similar to values
reported in other studies.38 The thermogram obtained for pure
PLA was indicative of its semi-crystalline nature, reinforcing the
result from the diffraction study. The inclusion of CS into the PLA
matrix shifted the glass transition temperature of the polymer
blend (A1) upward. The semi-crystalline nature of CS, as shown in
its diffraction proﬁle, was responsible for the shift being modest.
Nevertheless, the observed increase was attributed to CS obstruct-
ing the movement of PLA chains.39 The increase in crystallinity
with the addition of TCP into the polymer matrix was explained
by the former acting as a nucleation agent for crystallization.40
Since crystallinity has an inﬂuence on the rate of degradation, the
degradability of scaffolds can possibly be tailored by altering the
TCP content in the polymer matrix.
Morphology of Electrospun Resorbable Membranes
Figure 4 shows SEM micrographs of randomly oriented electro-
spun nano/microﬁbers of powder blends prepared in this study.
As can be seen, the PLA nanoﬁbers exhibited a round and smooth
surface morphology with an average diameter of 265.83 nm. The
ﬁbers generated from PLA/CS blends displayed a similar morphol-
ogy, however, with approximately a 30% increase in mean diame-
ter with a broader distribution. The inclusion of TCP lead to the
formation of signiﬁcantly broader ﬁbers of 891.83 and 1325.7 nm
at 2 and 4 wt % content, respectively. The bioceramic containing
ﬁbers experienced branching and seemed to have a rougher surface
even though the presence of TCP on the surface on the ﬁbers was
not evident from the micrographs.
It was difﬁcult to identify a common solvent to dissolve PLA and
chitosan for electrospinning because of the inherent dissimilarity
of these polymers. The beneﬁt of using TFA was twofold (a) it
facilitated the electrospinning of PLA nanoﬁbers by increasing the
solution conductivity and (b) destroyed the strong associations
between chitosan molecules and thereby facilitating the continu-
ous production of ﬁbers.41,42 The addition of chitosan increased
the ﬁber diameter by enhancing the viscosity of the solution, and
led to a broader distribution that was likely a consequence of
increased charge density.43 The increase of ﬁber diameter and dis-
tribution was reported in a previous work where similar concen-
trations of TCP were responsible for the inability of the polymer
chains to stretch.44 It is also likely that modiﬁcations to the visco-
elastic component of the rheological behavior of the solutions
changed the degree of swell experienced after extrusion from the
needle. It is possible that the diameter of the ﬁbers could have
inﬂuenced cell growth.45 Nevertheless, all the scaffolds showed
promise of being structurally similar to the collagen ﬁbers in the
bone as they fell within the range 100–2000 nm and the roughness
of the composite scaffolds were seen as a factor that may positively
inﬂuence cell attachment.46
Homogeneity of Electrospun Barrier Membranes
The average Raman spectra of 20 measurements captured for the
three raw materials and four electrospun composite membranes
is shown in Figure 5. These measurements were carried to con-
ﬁrm material homogeneity after membrane fabrication.
The results of the Raman spectroscopy reinforce the ﬁndings of
the powder investigation regarding the homogeneity of the mate-
rial produced, and conﬁrms this even distribution of materials is
maintained in its electrospun form. As the proportion of PLA in
the material falls from A0 to A3 the contribution of the PLA
component of the spectrum can be seen to reduce. Additionally,
it can be seen that the deviation from the mean spectrum is mod-
est, indicating that the composition of the material was similar at
all 20 sampling locations.
Cytotoxicity Study for Biocomposite Powder Blend
The cytocompatibility of the composite cryomilled powder blends
was tested on a murine macrophage cell line (RAW 264.7).
Results of the CTB assay [Figure 6(a,b)] indicate that 24 h after
returning to cultivation in standard medium, cell viability is
Figure 3. DSC second heating scans of the cryomilled composites.
Table I. Second Heating Scan Data from DSC Analysis
Material Tg(C) Tm(C)
X∘c
(%)
Hm
(J/g)
A0 57.6 177.5 15.2 14.5
A1 60.9 177 15.0 14.3
A2 62.7 177.6 23.9 22.3
A3 64 177.4 27.8 26.2
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statistically reduced with respect to the control for all the concen-
trations tested. However, 48 h after returning to standard
medium cultivation, the difference in cell viability between cells
incubated with different cryomilled powders and controls is
Figure 5. Baselined and normalized (to unit area) Raman spectra of each raw
material (PLA, CHI, TCP) and each type of electrospun scaffold (A0, A1, A2,
A3). Each spectrum represents the mean of 20 individual spectra with ±1SD.
Figure 6. CTB assay performed on RAW 264.7 cell line incubated with
composite cryomilled powders blend A0, A1, A2, and A3, considering dif-
ferent particles/cell loads, after (a) 24 h and (b) 48 h particle exposure in
standard medium conditions. Results are expressed as ﬂuorescence intensity
(relative ﬂuorescence unit-RFU) and are indicated as mean ± SD.
Figure 4. SEM images of ﬁbrous membranes with ﬁber diameters represented as mean ± SD.
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Figure 7. Representative bright-ﬁeld micrographs of RAW 264.7 macrophages incubated for 24 h with different composite cryomilled powders. (a) 10 and
(b) 30 particles/cell loads. (c) control; magniﬁcation = 200×; Scale bar = 20 μm.
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reduced, with no statistical difference seen between controls and
cells incubated with particles. Additionally, cell morphology was
investigated using bright-ﬁeld microscopy [Figure 7(a–c)]. No
morphological changes were seen in macrophages incubated with
composite cryomilled powders when compared to control macro-
phages grown in standard medium suggesting a low induction of
phagocytic response. In addition, these micrographs reveal that
particles, when suspended in culture medium, form agglomera-
tions, to which macrophages can be seen to adhere with subse-
quent cell proliferation.
The high particle dose per cell in biocompatibility test represents
an aggressive test of phagocytic response. The particle size
formed by cryomilling lies at the upper end of the phagocytic
range of macrophages.47 Particle agglomeration, as observed
in vitro, will act to further decrease the particles’ bioavailability.
The lack of morphological cues suggesting macrophagic
activation, and the lack of a sustained cell viability challenge
(i.e., viability recovery at 48 h) indicate that the cells may not be
ingesting signiﬁcant numbers of particles. Importantly, neither
are the cells signiﬁcantly perturbed by their extracellular interac-
tion with the biocomposite powders after an initial retardation of
their proliferation. Our results suggest that particle release should
not be a signiﬁcant source of biocompatibility challenges.
Performance Assessment of PLA/CS/TCP Biocomposite
Membranes
The viability of MG-63 cells was qualitatively examined by ﬂuo-
rescence and CARS microscopy at day 3 and 7 after cell seeding
onto scaffolds. All the scaffolds show high cell viability and low
number of dead cells, as shown in Figure 8. MG-63 cell viability
was evaluated also by CTB assay, at day 3 and 7 from cell seeding
into scaffolds (Figure 9). The results conﬁrm the observations
from the ﬂuorescence investigation, showing that cells are viable
at both time points investigated.
Cells were able to colonize the scaffolds, and proliferate on them.
There was evidence that the scaffolds containing CS (A1, A2, and
A3) appeared more suitable for cell attaching than scaffold A0, as
indicated by the pictures from ﬂuorescence and CARS micros-
copy, which show a higher number of cells. Scaffolds A1 and A3,
in particular, were noticed to have a good cell attachment along
scaffold ﬁbers. The results of the CTB assay reﬂected the observa-
tions made from the qualitative analysis. There was an increase
of registered ﬂuorescence intensity, corresponding to an increase
of cell viability, at day 7 with respect to day 3, indicating that
cells may be able to integrate inside the scaffolds and to grow on
them with the passing of days.
The aim of this study was to determine if osteoblast-like cells are
able to attach and proliferate on electrospun scaffolds. Although
no statistical difference was noticed among the different type of
scaffolds investigated, the promising results obtained on scaffolds
A1–A3 encourage additional investigations. Further study will
investigate induction and maintenance of osteoblastic phenotype
by following appropriate osteoblastic markers over extended
periods; such as, the alkaline phosphatase activity, the formation
Figure 8. Fluorescence microscopy on MG-63 cells seeded into electrospun
scaffolds. Scaffolds ﬁbers are depicted using CARS; Scale bar = 20 μm.
Figure 9. CTB assay performed on MG-63 cells seeded into electrospun
scaffolds, after 3 and 7 days from cell seeding. Results expressed as
ﬂuorescence intensity in Relative Fluorescence Units (RFU) and are indicated
as mean ± SD.
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of calcium phosphate and the expression of osteogenic genes such
as osteopontin and osteocalcin.48
CONCLUSIONS
Cytotoxicity testing on precursor powders used to manufacture
the scaffolds reveals a response from macrophages 24 h after
exposure to the powders, with their viability reduced when com-
pared to untreated controls. Biocompatibility of micron-sized
particles of material is known to diverge from the same material
in the bulk; all the materials that have been utilized have estab-
lished biocompatibility. While the particles lie at the upper bound
of the phagocytosable range, it is likely that at the high particle
loads used there will be sufﬁcient bio-available material to
impinge on cell viability. This effect could persist despite the ten-
dency of the powders to form large agglomerates when in sus-
pension. When nanoparticles aggregate, cytotoxicity may
potentially arise from many factors, hence it is difﬁcult to deﬁne
the causal factors of macrophage activation and the ultimate
cytotoxicity of the particles. However, after 48 h recovery period
of cultivation in standard medium the viability of the macro-
phages that were challenged with particles are comparable to that
of controls. This could be interpreted as a transient cell inhibition
by particles, allowing the cells to restore their viability and prolif-
eration activity. Importantly, electrospun ﬁbers scaffolds formed
by these powders show good biocompatibility and appear suitable
scaffolds for osteoblast-like cells, promoting adhesion and prolif-
eration. MG-63 cell morphology, being stellate not spherical,
shows good attachment to individual ﬁbers of the scaffolds, with
the cells’ growth increasing over time. These preliminary material
quality and biocompatibility experiments justify further investiga-
tion into the mechanical performance of the membranes and
longer-term cell response, to include osteogenesis and biodegra-
dation studies.
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